IP Library Granted Patent US 9,592,217
Granted Patent B2
US 9,592,217 · App. 15/062,936 · Granted Mar 14, 2017

Method for treating skin inflammatory diseases

Inventor: Joseph P. St. Laurent (Lakeville, MA)
Assignee: Olatec Therapeutics LLC
A61K31/275A61K9/0014A61K9/0053A61K9/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,592,217
App. No.
15/062,936
Granted
Mar 14, 2017
Kind
B2
Abstract

The present invention is directed to a method for treating skin inflammatory diseases such as dermatitis, psoriasis, and acne, and rosacea, by administering 3-methanesulfonylpropionitrile or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof. The method alleviates the symptoms of the disease treated. The active compound can be administered by a systemic route or topical route. Topical administration is a preferred route of administration.

Claims (7)

1. A method of treating an inflammatory skin disease or disorder, comprising the steps of:

identifying a subject in need thereof, and

administering to the subject 3-methanesulfonylpropionitrile, in an amount effective to reduce or eliminate the symptoms of the inflammatory skin disease or disorder.

2. The method according to claim 1 , wherein said 3-methanesulfonylpropionitrile is administered by topical administration.

3. The method according to claim 2 , wherein said 3-methanesulfonylpropionitrile is administered in a form of gel, cream, lotion, liquid, emulsion, ointment, spray, solution, suspension, and patches.

4. The method according to claim 1 , wherein said 3-methanesulfonylpropionitrile is administered by oral administration.

5. The method according to claim 4 , wherein said 3-methanesulfonylpropionitrile is administered in a form of tablets or capsules.

Assignments (2)
CHANGE OF NAME Recorded Nov 7, 2023
From: OLATEC THERAPEUTICS LLC
To: OLATEC THERAPEUTICS, INC.
Reel/Frame 065489/0809 →
CHANGE OF NAME Recorded Mar 18, 2016
From: OLATEC INDUSTRIES LLC
To: OLATEC THERAPEUTICS LLC
Reel/Frame 038177/0824 →
Continuity (5)
Continuation 14796809 · Jul 10, 2015
Continuation 14552366 · Nov 24, 2014
Continuation PCTUS2013043921 · Jun 3, 2013
Provisional Application 61655936 · Jun 5, 2012
Related Publication 20160256430A1 · Sep 8, 2016